Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have shown previously that
SNM1A
colocalizes with 53BP1 at sites of double-strand breaks (DSBs) induced by IR, and that these proteins interact with or without DNA damage. However, the role of
SNM1A
in the DNA damage response has not been elucidated. Here, we show that
SNM1A
is required for an efficient G1 checkpoint arrest after IR exposure. Interestingly, the localization of
SNM1A
to sites of DSBs does not require either 53BP1 or H2AX, nor does the localization of 53BP1 require
SNM1A
. However, the localization of
SNM1A
does require
ATM
. Furthermore,
SNM1A
is shown to be a phosphorylation substrate of
ATM
in vitro, and to interact with
ATM
in vivo particularly after exposure of cells to IR. In addition, in the absence of
SNM1A
the activation of the downstream
ATM
target p53 is reduced. These findings suggest that
SNM1A
acts with
ATM
to promote the G1 cell cycle checkpoint.
...
PMID:SNM1A acts downstream of ATM to promote the G1 cell cycle checkpoint. 1884 20